NCT02090153View on ClinicalTrials.gov

Study of S-1 Plus LV for Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

March 31, 2014

Conditions
Gastric Cancer
Interventions
DRUG

S-1

40\~60mg bid，d1\~7 q2W

DRUG

LV

LV is given simultaneously at a fixed dose of 25 mg b.i.d. on days 1-7, followed by a 7 day rest.

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Gaungzhou

All Listed Sponsors
collaborator

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sun Yat-sen University

OTHER

NCT02090153 - Study of S-1 Plus LV for Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter